PAK3
Serine/threonine-protein kinase PAK 3
Also known as: bPAK, hPAK3, MRX30, MRX47, PAK3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75914
- Gene
- PAK3
- Ensembl
- ENSG00000077264
- Chromosome
- X
- Canonical length
- 559 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
559 residues, UniProt reviewed canonical sequence.
>O75914|PAK3
1 MSDGLDNEEK PPAPPLRMNS NNRDSSALNH SSKPLPMAPE EKNKKARLRS IFPGGGDKTN
61 KKKEKERPEI SLPSDFEHTI HVGFDAVTGE FTPDLYGSQM CPGKLPEGIP EQWARLLQTS
121 NITKLEQKKN PQAVLDVLKF YDSKETVNNQ KYMSFTSGDK SAHGYIAAHP SSTKTASEPP
181 LAPPVSEEED EEEEEEEDEN EPPPVIAPRP EHTKSIYTRS VVESIASPAV PNKEVTPPSA
241 ENANSSTLYR NTDRQRKKSK MTDEEILEKL RSIVSVGDPK KKYTRFEKIG QGASGTVYTA
301 LDIATGQEVA IKQMNLQQQP KKELIINEIL VMRENKNPNI VNYLDSYLVG DELWVVMEYL
361 AGGSLTDVVT ETCMDEGQIA AVCRECLQAL DFLHSNQVIH RDIKSDNILL GMDGSVKLTD
421 FGFCAQITPE QSKRSTMVGT PYWMAPEVVT RKAYGPKVDI WSLGIMAIEM VEGEPPYLNE
481 NPLRALYLIA TNGTPELQNP ERLSAVFRDF LNRCLEMDVD RRGSAKELLQ HPFLKLAKPL
541 SSLTPLIIAA KEAIKNSSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 19 nTPM
- cerebral cortex: 19 nTPM
- hypothalamus: 15 nTPM
- pituitary gland: 13 nTPM
- hippocampal formation: 9.6 nTPM
- basal ganglia: 9.3 nTPM
Single-cell type
- lactotrophs: 1,044 nCPM
- sertoli cells: 877 nCPM
- pancreatic islet cells: 827 nCPM
- thyrotrophs: 827 nCPM
- somatotrophs: 747 nCPM
- pituicytes/fscs: 629 nCPM
Immune cell
- MAIT T-cell: 1 nTPM
- basophil: 0.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- hypothalamus: 129 nTPM
- cerebral cortex: 98 nTPM
- basal ganglia: 92 nTPM
- hippocampal formation: 85 nTPM
- pons: 76 nTPM
- amygdala: 74 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PAK3.
Disease | AllUniProt
Conditions PAK3 is implicated in, by any mechanism.
- Intellectual developmental disorder, X-linked 30 (XLID30) MIM:300558
Disease | GeneticClinVar
31 pathogenic / likely-pathogenic of 300 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, X-linked 30
- Intellectual disability
- Inborn genetic diseases
- History of neurodevelopmental disorder
- Thyroid cancer, nonmedullary, 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 3.53
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axonogenesis
- cell migration
- cellular response to starvation
- dendrite development
- dendritic spine morphogenesis
- ephrin receptor signaling pathway
- intracellular signal transduction
- regulation of actin cytoskeleton organization
- regulation of actin filament polymerization
- regulation of axonogenesis
- regulation of MAPK cascade
- regulation of postsynapse organization
- stimulatory C-type lectin receptor signaling pathway
- synapse organization
Molecular functions
- ATP binding
- MAP kinase kinase activity
- metal ion binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- SH3 domain binding
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CRIB domain
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- p21 activated kinase binding domain
- CRIB domain superfamily
- Serine/threonine-protein kinase PAK 3-like
- Protein kinase domain
- P21-Rho-binding domain
- p21-activated kinase 3, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PAK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAK3 as an antibody target. Whether an autoantibody or antibody against PAK3 could matter depends on whether native PAK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAK3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PAK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...